Triodos Bank NV

Triodos Bank NV has a fully diluted share count of 14,467,056 shares, with no difference between basic and diluted shares outstanding, indicating no dilution pressure from stock options or convertible instruments. The liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The bank's profitability and returns are not yet quantified in the valuation snapshot, and no industry-specific preferred metrics are available for comparison. This suggests a need for further analysis of its return on equity (ROE), net interest margin (NIM), and cost-to-income ratio to evaluate its performance relative to industry benchmarks.

Triodos Bank NV's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is difficult to assess the diversification of its revenue streams or the extent of its international operations.

The growth trajectory of Triodos Bank NV is not quantified in the outlook data. Analysts have provided a mean price target of 35.20 EUR and a median price target of 30.00 EUR, with a mean recommendation of 2.33 (indicating a "Hold" or "Market Outperform" rating). However, no numeric deltas or revenue growth projections are available to assess the company's future performance.

The risk assessment indicates a low dilution risk, with no near-term pressure from equity issuance or convertible instruments. However, the liquidity risk remains unassessed due to the lack of balance-sheet inputs and no going-concern language in source documents.

Recent events, including filings and transcripts, are not disclosed in the available data. Analysts have issued one "Strong Buy" and two "Hold" recommendations, with no "Buy" ratings, suggesting a cautious outlook on the stock.

Total assets grew 3.5% year-over-year to EUR 17.6 billion, indicating continued balance sheet expansion despite recent profitability challenges.

A four-year revenue CAGR of 10.6% demonstrates historical top-line growth momentum prior to the recent fiscal decline.

Analysts maintain a buy recommendation with a mean price target of EUR 35.2, suggesting potential upside from current levels.

Dilution risk is assessed as low, providing some stability for existing shareholders regarding equity structure integrity.

Long-term debt surged to EUR 907.7 million in the latest period, significantly increasing leverage and financial risk.

Revenue declined 4.8% year-over-year to EUR 331.1 million, marking the first contraction in the five-year trend.

Equity decreased 3.3% year-over-year to EUR 1.19 billion, reflecting capital erosion amid mounting losses.